Home › Markets › Health Care › ITGR

Integer Holdings Corporation (ITGR)

ITGR trades on NYSE in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$126.59
+0.06% on the day
Market cap
$4.3B
Mid cap
Revenue · 2025
$1.9B
+8.0% on 2024
Net income · 2025
$102.8M
5.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerITGR on NYSE
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001114483
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.9B
Net income$102.8M
Operating income$221.3M
Net margin5.5%
Operating margin11.9%
Revenue growth+8.0%
Cash$17.2M
Total assets$3.4B
P/E (computed)41.9×
P/S (computed)2.3×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2016-04-28
Latest annual report10-K2026-02-23
Latest quarterly / interim10-Q2026-08-04
Latest current report
FORM 8-K
8-K2026-10-14
Latest proxyDEFM14A2026-09-14

Source: SEC EDGAR submissions feed, 1,008 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.0%
1 month+0.3%
3 months+27.1%
Year to date+61.4%
1 year+24.0%
From 52-week high-0.0%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
LIVNLivaNova PLC$76.37-1.17%$4.2B
TMDXTransMedics Group Inc.$79.14+1.23%$2.7B
AXGNAxogen Inc.$36.17-2.53%$2.1B
CNMDCONMED Corporation$45.55+0.42%$1.4B
CBLLCeriBell Inc.$26.14+3.48%$1.0B
INMDInMode Ltd.$14.30+0.04%$822.3M
CVCapsoVision Inc.$6.78+0.30%$360.7M
ELMDElectromed Inc.$27.68-1.53%$229.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier